53,551 Shares in Solventum Corporation $SOLV Purchased by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio acquired a new position in shares of Solventum Corporation (NYSE:SOLV) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 53,551 shares of the company’s stock, valued at approximately $4,131,000.

Several other hedge funds have also recently bought and sold shares of the company. CrossGen Wealth LLC acquired a new position in shares of Solventum in the 4th quarter valued at approximately $25,000. Measured Wealth Private Client Group LLC bought a new position in Solventum in the third quarter valued at approximately $25,000. Clearstead Trust LLC raised its position in Solventum by 61.0% during the first quarter. Clearstead Trust LLC now owns 396 shares of the company’s stock valued at $26,000 after purchasing an additional 150 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new stake in shares of Solventum in the 2nd quarter valued at $28,000. Finally, Modus Advisors LLC bought a new position in shares of Solventum in the 4th quarter valued at $30,000.

Solventum Stock Up 0.6%

Shares of SOLV opened at $92.44 on Friday. Solventum Corporation has a 52 week low of $62.38 and a 52 week high of $94.16. The stock has a market capitalization of $15.74 billion, a price-to-earnings ratio of 11.30, a PEG ratio of 1.43 and a beta of 0.61. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.74 and a current ratio of 1.02. The stock has a fifty day moving average of $83.76 and a 200-day moving average of $75.90.

Solventum (NYSE:SOLV) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.91 by $0.64. The business had revenue of $2.21 billion for the quarter, compared to analyst estimates of $2.15 billion. Solventum had a return on equity of 25.09% and a net margin of 17.26%.Solventum’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.69 EPS. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. As a group, sell-side analysts anticipate that Solventum Corporation will post 7.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on SOLV shares. Wall Street Zen cut Solventum from a “buy” rating to a “hold” rating in a report on Saturday, August 22nd. BTIG Research lifted their target price on Solventum from $91.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. KeyCorp boosted their target price on Solventum from $93.00 to $102.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Weiss Ratings raised shares of Solventum from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, August 18th. Finally, Mizuho set a $113.00 price target on shares of Solventum in a research note on Thursday, August 6th. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $91.64.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.